Table 1 Causal effects of CHB on COVID-19 outcomes
From: Causal associations between chronic hepatitis B and COVID-19 in East Asian populations
Outcome | Method | Beta | SE | OR (95% CI) | P |
|---|---|---|---|---|---|
Susceptibility | IVW-MRE | 0.042 | 0.014 | 1.042 (1.014–1.072) | 3.39E−03 |
Susceptibility | IVW-FE | 0.042 | 0.017 | 1.042 (1.009–1.077) | 1.32E−02 |
Susceptibility | MR Egger | 0.109 | 0.056 | 1.115 (0.998–1.245) | 5.93E−02 |
Susceptibility | Weighted median | 0.048 | 0.025 | 1.049 (1.000–1.102) | 5.19E−02 |
Susceptibility | Weighted mode | 0.055 | 0.049 | 1.056 (0.960–1.162) | 2.64E−01 |
Hospitalization | IVW-MRE | 0.093 | 0.017 | 1.097 (1.061–1.135) | 7.31E−08 |
Hospitalization | IVW-FE | 0.093 | 0.018 | 1.097 (1.060–1.136) | 1.51E−07 |
Hospitalization | MR Egger | 0.164 | 0.060 | 1.178 (1.048–1.325) | 8.39E−03 |
Hospitalization | Weighted median | 0.085 | 0.026 | 1.089 (1.035–1.146) | 9.69E−04 |
Hospitalization | Weighted mode | 0.048 | 0.050 | 1.049 (0.952–1.156) | 3.41E−01 |
Severity | IVW-MRE | 0.152 | 0.040 | 1.164 (1.076–1.259) | 1.43E−04 |
Severity | IVW-FE | 0.152 | 0.043 | 1.164 (1.070–1.267) | 4.18E−04 |
Severity | MR Egger | 0.166 | 0.141 | 1.181 (0.896–1.558) | 2.45E−01 |
Severity | Weighted median | 0.148 | 0.061 | 1.159 (1.029–1.306) | 1.52E−02 |
Severity | Weighted mode | 0.106 | 0.099 | 1.112 (0.916–1.348) | 2.89E−01 |